Skip to main content

Ongoing FDAEvent 99892 (27 days ago)

ICU Medical 0.9% Sodium Chloride Injection

0.9% Sodium Chloride Injection may be mixed up with Potassium Chloride Injection, which can cause adverse events and potentially fatal outcomes.

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

3 photos

What to do

What happened

Otsuka ICU Medical LLC is voluntarily recalling one lot of 0.9% Sodium Chloride Injection, USP, 100 mL, due to a potential mix-up. The product may contain an overwrap labeled as 0.9% Sodium Chloride Injection, but the actual product within the overwrap may be Potassium Chloride Injection, 10 mEq.

The affected lot was manufactured on 13 November 2025 and distributed in the United States between 30 December 2025 and 22 June 2026. The recall was initiated on September 11, 2026, and announced on September 17, 2026. The product is manufactured by ICU Medical, Inc., Lake Forest, Illinois.

Summary by Recall Canary from the FDA notice.

What to do

If a code on your package matches:

  1. Otsuka ICU Medical LLC is notifying its customers, including distributors, of this recall by letter and is requesting the return of all recalled products.
  2. All customers, including distributors, should check inventory locations within their institution for the affected product in Table 1, quarantine, and discontinue use.
  3. Upon receipt of the completed response form, ICU Medical Customer Service will contact customers to coordinate a return label and instructions for product return.
  4. For further inquiries, please contact ICU Medical using the information provided below. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online: www.fda.gov/medwatch/report.htm.

Is yours affected?

Compare every listed detail under your product with its label.

  1. 0.9% Sodium Chloride Injection, USP

    NDC
    • 0990-7984-23
    Lot code
    • 1042188
    Best-by
    31 October 2027
    List number
    • 07984-23
    Configuration
    100 mL in flexible container
    Label example
    See below

Details

Company began the recall
Sold in

Affected Product: The affected product lot was manufactured on 13 November 2025 and distributed in the United States between 30 December 2025 and 22 June 2026.

Event ID
99892
Company
Otsuka ICU Medical LLC
Quantity recalled
258,480 container
  1. Company began the recall

  2. Announced by the company

  3. Listed on Recall Canary

  4. Added to FDA's Enforcement Report

  5. In FDA's weekly enforcement report

  6. Classified by FDA

  7. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 7, 2026 · primary source: U.S. Food and Drug Administration